HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Pablo Colorado Selected Research
Pablo Colorado Research Topics
Disease
4
Stroke (Strokes)
05/2024 - 01/2022
4
Ischemic Stroke
05/2024 - 01/2022
3
Pulmonary Hypertension
01/2017 - 05/2015
2
Thrombosis (Thrombus)
11/2023 - 01/2022
2
Hemorrhage
11/2023 - 01/2022
2
Pulmonary Arterial Hypertension
01/2017 - 01/2017
1
Embolic Stroke
01/2024
1
Transient Ischemic Attack
01/2024
1
Infarction (Infarctions)
01/2024
1
Brain Infarction
01/2024
1
Cerebral Small Vessel Diseases
11/2023
1
Body Weight (Weight, Body)
02/2021
1
Heart Failure
02/2021
1
Neoplasms (Cancer)
11/2008
Drug/Important Bio-Agent (IBA)
4
Factor XIa (Coagulation Factor XIa)
IBA
05/2024 - 01/2022
4
riociguat
IBA
01/2017 - 05/2015
2
Soluble Guanylyl Cyclase
IBA
01/2016 - 05/2015
1
Anticoagulants
IBA
01/2024
1
Antidiuretic Hormone Receptor Antagonists
IBA
02/2021
1
Creatinine
IBA
02/2021
1
Nitrogen
IBA
02/2021
1
Urea (Carbamide)
FDA Link
Generic
02/2021
1
Vasopressin Receptors (Arginine Vasopressin Receptor)
IBA
02/2021
1
Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)
IBA
02/2021
1
Type 5 Cyclic Nucleotide Phosphodiesterases
IBA
01/2017
1
Integrin alpha1
IBA
11/2008
1
Collagen
IBA
11/2008
1
Integrin alpha1beta1
IBA
11/2008
Therapy/Procedure
4
Therapeutics
05/2024 - 02/2021
1
Secondary Prevention
01/2022
1
Endarterectomy (Thromboendarterectomy)
01/2016